Alterity Therapeutics to Present at the H.C. Wainwright BIOC

MELBOURNE, Australia, Jan. 5, 2022 /PRNewswire/ -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today... | January 5, 2022

Related Keywords

Australia , California , United States , Melbourne , Victoria , San Francisco , David Stamler , Securities Exchange , Alterity Therapeutics , Nasdaq , Chief Executive Officer , Securities Act , Securities Exchange Act , Annual Report , Alterity Therapeutics Limited Stock Exchange , News , Information , Press Release , 022 , Alterity , Herapeutics , Biotechnology , Company , Edicated , O , Developing , Disease , Modifying , Treatments , Or , Eurodegenerative Athe Us02155x1063 ,